Trends in Cardiovascular Medicine
Volume 17, Issue 4 , Pages 124-128 , May 2007

Vascular Calcification and Fetuin-A Deficiency in Chronic Kidney Disease

  • Ralf Westenfeld

      Affiliations

    • Department of Nephrology and Clinical Immunology, Klinikum Coburg, Coburg, Germany
    • ,
  • Willi Jahnen-Dechent

      Affiliations

    • IZKF BioMAT, University Hospital Aachen, Klinikum Coburg, Coburg, Germany
    • ,
  • Markus Ketteler

      Affiliations

    • Department of Nephrology and Clinical Immunology, Klinikum Coburg, Coburg, Germany
    • Department of Nephrology and Hypertension, Klinikum Coburg, Coburg, Germany
    • Corresponding Author InformationAddress correspondence to: Dr. Markus Ketteler, III. Medizinische Klinik: Nephrologie und Hypertensiologie, Klinikum Coburg, Ketschendorfer Str. 33, D-96450 Coburg, Germany. Tel.: (+49) 9561-249611; fax: (+49) 9561-249612
    • M. K. is supported by a grant from the Interdisciplinary Centre for Clinical Research “BIOMAT” of the faculty of Medicine at the RWTH Aachen University (TV B67).

References 

  1. Ashton BA, Höhling H-J, Triffitt JT. Plasma proteins present in human cortical bone: enrichment of the a2HS-glycoprotein. Calcif Tissue Res. 1976;22:27–33
  2. Block GA, Klassen PS, Lazarus JM, et al. Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. JAm Soc Nephrol. 2004;15:2208–2218
  3. Block GA, Spiegel DM, Ehrlich J, et al. Effects of sevelamer and calcium on coronary artery calcification in patients new to hemodialysis. Kidney Int. 2005;68:1815–1824
  4. Brandenburg VM, Westenfeld R, Busch B, et al. Sevelamer treatment in HD patients increases fetuin-A serum levels without reducing CRP or uremic toxins. JAm Soc Nephrol. 2006;17:F-O560;(abstract)
  5. Braun J, Oldendorf M, Moshage W, et al. Electron beam computed tomography in the evaluation of cardiac calcification in chronic dialysis patients. Am J Kidney Dis. 1996;27:394–401
  6. Chen NX, O'neill KD, Chen X, et al. Fetuin-A uptake in bovine vascular smooth muscle cells (BVSMC) is calcium dependent and mediated by annexins. Am J Physiol Renal Physiol. 2007;292:F599–F606
  7. Demetriou M, Binkert C, Sukhu B, et al. Fetuin/alpha2-HS glycoprotein is a transforming growth factor-beta type II receptor mimic and cytokine antagonist. JBiol Chem. 1996;271:12755–12761
  8. Dziegielewska KM, Matthews N, Saunders NR, Wilkinson G. Alpha2HS-glycoprotein is expressed at high concentration in human fetal plasma and cerebrospinal fluid. Fetal Diagn Ther. 1993;8:22–27
  9. Fiore CE, Celotta G, Politi GG, et al. Association of high alpha(2)-Heremans-Schmid glycoprotein/fetuin concentration in serum and intima-media thickness in patients with atherosclerotic vascular disease and low bone mass. Atherosclerosis. 2006;[Epub ahead of print]
  10. Giachelli C. Vascular calcification mechanisms. J Am Soc Nephrol. 2004;15:2959–2964
  11. Goodman WG, Goldin J, Kuizon BD, et al. Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl J Med. 2000;342:1478–1483
  12. Guerin AP, London GM, Marchais SJ, Metiview F. Arterial stiffening and vascular calcifications in end-stage renal disease. Nephrol Dial Transplant. 2000;15:1014–1021
  13. Heiss A, DuChesne A, Denecke B, et al. Structural basis of calcification inhibition by alpha 2-HS glycoprotein/fetuin-A. Formation of colloidal calciprotein particles. JBiol Chem. 2003;278:13333–13341
  14. Ix JH, Chertow GM, Shlipak MG, et al. Fetuin-A and kidney function in persons with coronary artery disease—data from the heart and soul study. Nephrol Dial Transplant. 2006;21:2144–2151
  15. Ix JH, Shlipak MG, Brandenburg VM, et al. Association between human fetuin-A and the metabolic syndrome: data from the Heart and Soul study. Circulation. 2006;113:1760–1767
  16. Jahnen-Dechent W. Lot's wife's problem revisited: how we prevent pathological calcification. In:  Baeuerlein E editors. Biomineralization Progress in Biology, Molecular Biology and Application.. 2nd ed. Weinheim: Wiley-VCH; 2004;p. 60–69
  17. Jahnen-Dechent W, Schäfer C, Heiss A, Grötzinger J. Systemic inhibition of spontaneous calcification by the serum protein alpha 2-HS glycoprotein/fetuin. ZKardiol. 2001;3(90Suppl):47–56
  18. Jono S, McKee MD, Murry CE, et al. Phosphate regulation of vascular smooth muscle cell calcification. Circ Res. 2000;87:E10–E17
  19. Kalantar-Zadeh K, Kuwae N, Regidor DL, et al. Survival predictability of time-varying indicators of bone disease in maintenance hemodialysis patients. Kidney Int. 2006;70:771–780
  20. Ketteler M. Fetuin-A and extraosseous calcification in uremia. Curr Opin Nephrol Hypertens. 2005;14:337–342
  21. Ketteler M, Bongartz P, Westenfeld R, et al. Association of low fetuin-A (AHSG) concentrations in serum with cardiovascular mortality in patients on dialysis: a cross-sectional study. Lancet. 2003;361:827–833
  22. Ketteler M, Schlieper G, Ketteler M, Floege J. Calcification and cardiovascular health: new insights into an old phenomenon. Hypertension. 2006;47:1027–1034
  23. Lebreton JP, Joisel F, Raoult JP, et al. Serum concentration of human alpha 2 HS glycoprotein during the inflammatory process: evidence that alpha 2 HS glycoprotein is a negative acute-phase reactant. J Clin Invest. 1979;64:1118–1129
  24. London GM, Guerin AP, Marchais SJ, et al. Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality. Nephrol Dial Transplant. 2003;18:1731–1740
  25. Mathews ST, Rakhade S, Zhou X, et al. Fetuin-null mice are protected against obesity and insulin resistance associated with aging. BBRC. 2006;350:437–443
  26. Mehrotra R, Westenfeld R, Christenson P, et al. Serum fetuin-A in nondialyzed patients with diabetic nephropathy: relationship with coronary artery calcification. Kidney Int. 2005;67:1070–1077
  27. Merx M, Schäfer C, Westenfeld R, et al. Myocardial stiffness, cardiac remodeling and diastolic dysfunction in calcification-prone fetuin-A deficient mice. J Am Soc Nephrol. 2005;16:3357–3364
  28. Mizuno M, Farach Carson MC, et al. Identification of the rat bone 60K acidic glycoprotein as alpha 2HS-glycoprotein. Bone Miner. 1991;13:1–21
  29. Moe SM, Reslerova M, Ketteler M, et al. Role of calcification inhibitors in the pathogenesis of vascular calcification in chronic kidney disease (CKD). Kidney Int. 2005;67:2295–2304
  30. Oh J, Wunsch R, Turzer M, et al. Advanced coronary and carotid arteriopathy in young adults with childhood-onset chronic renal failure. Circulation. 2002;106:100–105
  31. Reynolds JL, Skepper JN, McNair R, et al. Multifunctional roles for serum protein fetuin-A in inhibition of human vascular smooth muscle cell calcification. J Am Soc Nephrol. 2005;16:2920–2930
  32. Schäfer C, Heiss A, Schwarz A, et al. The serum protein alpha 2-Heremans-Schmid glycoprotein/fetuin-A is a systemically acting inhibitor of ectopic calcification. J Clin Invest. 2003;112:357–366
  33. Schinke T, Amendt C, Trindl A, et al. The serum protein alpha2-HS glycoprotein/fetuin inhibits apatite formation in vitro and in mineralizing calvaria cells. A possible role in mineralization and calcium homeostasis. J Biol Chem. 1996;271:20789–20796
  34. Stenvinkel P, Wang K, Qureshi AR, et al. Low fetuin-A levels are associated with cardiovascular death: impact of variations in the gene encoding fetuin. Kidney Int. 2005;67:2383–2392
  35. Terkelsen OB, Jahnen-Dechent W, Nielsen H, et al. Rat fetuin: distribution of protein and mRNA in embryonic and neonatal rat tissues. Anat Embryol. 1998;197:125–133
  36. Tomiyama C, Higa A, Dalboni MA, et al. The impact of traditional and non-traditional risk factors on coronary calcification in pre-dialysis patients. Nephrol Dial Transplant. 2006;21:2464–2471
  37. Triffitt JT, Gebauer U, Ashton BA, et al. Origin of plasma alpha2HS-glycoprotein and its accumulation in bone. Nature. 1976;262:226–227
  38. Vliegenthart R, Hollander M, Breteler MM, et al. Stroke is associated with coronary calcification as detected by electron-beam CT: the Rotterdam Coronary Calcification Study. Stroke. 2002;33:462–465
  39. Vliegenthart R, Oudkerk M, Song B, et al. Coronary calcification detected by electron-beam computed tomography and myocardial infarction. The Rotterdam Coronary Calcification Study. Eur Heart J. 2002;23:1596–1603
  40. Wang AY, Woo J, Wang M, et al. Association of inflammation and malnutrition with cardiac valve calcification in continuous ambulatory peritoneal dialysis patients. J Am Soc Nephrol. 2002;12:1927–1936
  41. Wang AY, Woo J, Lam CW, et al. Associations of serum fetuin-A with malnutrition, inflammation, atherosclerosis and valvular calcification syndrome and outcome in peritoneal dialysis patients. Nephrol Dial Transplant. 2005;20:1676–1685
  42. Westenfeld R, Schäfer C, Haarmann C, et al. Fetuin-A deficiency aggravates vascular calcification in apolipoproteinE deficient mice—role of phosphate and renal insufficiency. J Am Soc Nephrol. 2006;17:SA-FC153;(abstract)
  43. Wilson JM, Ashton B, Triffitt JT. The interaction of a component of bone organic matrix with the mineral phase. Calcif Tissue Res. 1997;22:458–460

PII: S1050-1738(07)00049-7

doi: 10.1016/j.tcm.2007.02.005

Trends in Cardiovascular Medicine
Volume 17, Issue 4 , Pages 124-128 , May 2007

Article Tools

* Image Usage & Resolution